Stay updated on Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The screenshots indicate only minor UI/layout updates with no changes to core study content (title, objectives, eligibility, endpoints, or locations). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T20:56:31.000Z thumbnail image
  3. Check
    35 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    3%
    Check dated 2025-10-06T08:12:23.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T04:42:34.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, indicating a new release; the 'Back to Top' navigation element was removed as a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T23:10:58.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T19:48:46.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new medical topics related to colorectal cancer and various proteins. Notably, the previous version's details about pembrolizumab have been removed, indicating a shift in focus.
    Difference
    2%
    Check dated 2025-08-31T12:33:53.000Z thumbnail image

Stay in the know with updates to Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.